eISSN 2508-3589
pISSN 2508-1926

Fig. 6.

Download original image
Fig. 6. Mean change in best-corrected visual acuity and central macular thickness at baseline, after last aflibercept injection(A), and after switching to three injections of ranibizumab(R). CMT = central macular thickness; BCVA = best-corrected visual acuity; logMAR = logarithm of the minimum angle of resolution. *p < 0.05.
J Retin 2021;6:99-109 https://doi.org/10.21561/jor.2021.6.2.99
© 2021 J Retin